Sonnest, Inc. Announces Completion of an Oversubscribed Series A Financing

By |2021-06-02T09:24:29-04:00June 2nd, 2021|

Sonnest Has Received over $4M in the Series A Financing to Fund the Initial Evaluation of Electrast™ – the Company’s Voltage Activated Ultrasound Imaging Drug